Shamrock Industrial Co Ltd Management Discussions.

Your Directors are pleased to present the Management Discussion and Analysis Report for the year ended 31st March, 2020.

The Management Discussion and Analysis have been included in consonance with the Code of Corporate Governance as approved by The Securities and Exchange Board of India (SEBI). Investors are cautioned that these discussions contain certain forward looking statements that involve risk and uncertainties including those risks which are inherent in the Companys growth and strategy. The company undertakes no obligation to publicly update or revise any of the opinions or forward looking statements expressed in this report consequent to new information or developments, events or otherwise.

The management of the company is presenting herein the overview, opportunities and threats, initiatives by the Company and overall strategy of the company and its outlook for the future. This outlook is based on managements own assessment and it may vary due to future economic and other future developments in the country.

The operational performance and future outlook of the business has been reviewed by the management based on current resources and future development of the Company.


Your Companys main object is cornered in to dealers and manufacturing of pharmaceutical products and services. Since 10 years your Company is non-operative. The main reason of occurring losses is due to day to day routine Expenses. The management of the Company wants to revive the Company and very optimistic regarding performance of the Company in future and taking every steps and making every efforts to turn the Company in to profitable organization.

Particulars F.Y. 2020 2021 F.Y. 2019 2020
(Rs. In Lacs) (Rs. In Lacs)
Revenue from Operation - -
Revenue from other Income 0.80 -
Total Revenue 0.80 -
Profit before Dep. & Int. - -
Depreciation - -
Interest - -
Profit after Depreciation & Interest (31.38) (21.95)
Provision for Taxation - -
Provision for Tax (deferred) - -
Provision for Taxation for earlier year - -
Profit/ Loss after Tax (31.38) (21.95)
EPS (0.58) (0.40)

INDUSTRY STRUCTURE AND DEVELOPMENTS: Pharmaceutical Sector Overview - Global

India continued to be one of the most robust and resilient economies of the world in 2021. During F.Y.2020-21, the economy grew by 7.30%, suffering primarily from inadequate credit availability owing to challenges in the financial sector. The combined impact of muted domestic demand and export markets dragged down capacity utilization of industries.

The Government of India undertook proactive initiatives such as reducing corporate tax rates and offering credit guarantee for financially sound Non-Banking Financial Corporations (NBFCs). The year also witnessed easing of monetary policy by the Reserve Bank of India (RBI) with significant reduction in the repo rate. Driven by fiscal and monetary policy initiatives, the economy began to show early signs of recovery. However, the COVID-19 outbreak in the fourth quarter of the year made recovery an uphill task.

The World Health Organization has declared the novel coronavirus (COVID- 19) as a pandemic on March 11, 2020, besides the impact of this outbreak on human life; it has also disrupted the financial, economic and social structures of the entire world. The Central Government in India also declared a national lockdown from March 25, 2020 to May 31, 2020, through various notifications, and subsequently the Central Government has announced Unlock 1.0 till June 30, 2020. During the unlock 1.0 period private offices are allowed to operate with 10% of the staff with certain conditions initially and restricted the movement as a preventive/ precautionary measures to avoid the spread of COVID- 19.


As there are no subsidiaries of the Company, Investment made in Subsidiaries is NIL.


The company is not in operation since 11 years.


In accordance with the amended SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company is required to give details of significant changes (i.e. change of 25% or more as compared to the immediately previous financial year) in key financial ratios, along with detailed explanations thereof:

The Company has identified following ratios as key financial ratios:

Particular F.Y. 2020-21 F.Y. 2019-20 % Change
Debtors Turnover Ratio - - -
Inventory Turnover Ratio - - -
Interest Coverage Ratio - - -
Current Ratio 37.46 56.08 -49.71%
Debt Equity Ratio 0.03 0.02 33.33%
Operating Profit Margin (%) - - -
Net Profit Margin (%) - - -
Return on Net Worth RONW (%) -0.15% -0.19% 26.67%


During the year under review, the performance of the Board & Committees and Individual Director(s) based on the below parameters was satisfactory:

a) Most of the Directors attended the Board meetings;

b) The remunerations paid to executive Directors are strictly as per the company and industry policy.

c) The Independent Directors only received sitting fees.

d) The Independent Directors contributed in the Board and committee deliberation and business and operation of the company based on their experience and knowledge and Independent views.

e) Risk Management Policy was implemented and monitored by the Auditors.


The Companys future development would depend upon the commencement of its operational activities.


The Company is following a proper and adequate system of internal controls in respect of all its activities. Further all transaction entered into by the Company are fully authorised, recorded and reported correctly.


The Company has excellent combination of experienced and talented employees. The Company also undertakes on regular basis various training programmers to keep its employees updated on new technical developments and information which directly results in optimum capacity utilization and cost effectiveness. The Companys relation with its employees continues to be cordial. The Company always reciprocates commitment to its employees in order to motivate them to perform the best.


Statements in foregoing paragraphs of this report describing the current industry structure, outlook, opportunities, etc., may be construed as "forward looking statements", based on certain assumptions of future events over which the Company exercises no control. Therefore, there can be no guarantee as to their accuracy. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those that may be implied by these forward looking statements.